HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.

AbstractPURPOSE:
Post-mortem and in-vivo MRI data suggest an accumulation of iron in the brain of Alzheimer's disease (AD) patients. The majority of studies in clinically diagnosed AD patients found an increase of iron-sensitive MRI signals in the putamen. As the clinical diagnosis shows only a moderate sensitivity, Aβ-PET was used to further stratify patients with the clinical diagnosis of AD. Aim of this exploratory study was to examine whether Aβ-positive (AD) and Aβ-negative (non-AD) patients differ in their regional magnetic susceptibility compared to healthy controls (HCs) and whether regional susceptibility values correlate with mini mental state examination (MMSE) scores or global Aβ-load.
METHODS:
We retrospectively analyzed [11C]PiB PET/MRI data of 11 HCs, 16 AD and 10 non-AD patients. We used quantitative susceptibility mapping (QSM) as iron-sensitive MRI signal measured at the 3 T PET/MR scanner. Global cerebral Aβ-load was determined by composite [11C]PiB SUV ratios.
RESULTS:
Compared to HCs, AD patients showed higher QSM values in putamen (0.049 ± 0.033 vs. 0.002 ± 0.031; p = 0.006), while non-AD patients showed lower QSM values in caudate nucleus (0.003 ± 0.027 vs. 0.051 ± 0.039; p = 0.006). There was a trend towards a significant correlation between putaminal QSM and MMSE values (ρ=-0.340, p = 0.053). In AD patients, global Aβ-load and putaminal QSM values were significantly correlated (ρ=-0.574, p = 0.020).
CONCLUSIONS:
These data indicate that AD and non-AD patients may show different cerebral iron pathologies which might be detectable by QSM MRI, and might be linked to neurodegeneration. Overall, the data encourage further investigations in well-defined patient cohorts to clarify the value of QSM/magnetic susceptibility in the course of neurodegenerative diseases and its potential as diagnostic biomarker.
AuthorsSolveig Tiepolt, Michael Rullmann, Thies H Jochimsen, Hermann-Josef Gertz, Matthias L Schroeter, Marianne Patt, Osama Sabri, Henryk Barthel
JournalEuropean journal of radiology (Eur J Radiol) Vol. 131 Pg. 109243 (Oct 2020) ISSN: 1872-7727 [Electronic] Ireland
PMID32916411 (Publication Type: Evaluation Study, Journal Article)
CopyrightCopyright © 2020. Published by Elsevier B.V.
Chemical References
  • Amyloid beta-Peptides
  • Iron
Topics
  • Aged
  • Alzheimer Disease (metabolism, pathology)
  • Amyloid beta-Peptides (metabolism)
  • Brain (diagnostic imaging, metabolism, pathology)
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Iron (metabolism)
  • Magnetic Resonance Imaging (methods)
  • Male
  • Multimodal Imaging (methods)
  • Positron-Emission Tomography (methods)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: